| # | Title | Journal | Year | Citations |
|---|
| 1 | Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver | Hepatology | 2014 | 1,498 |
| 2 | ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment | Journal of Crohn's and Colitis | 2020 | 741 |
| 3 | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis | Nature Reviews Gastroenterology and Hepatology | 2019 | 571 |
| 4 | ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment | Journal of Crohn's and Colitis | 2020 | 478 |
| 5 | Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation | Nutrients | 2018 | 328 |
| 6 | Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study | Journal of Hepatology | 2014 | 282 |
| 7 | A Randomized, Controlled Trial of Transanal Irrigation Versus Conservative Bowel Management in Spinal Cord–Injured Patients | Gastroenterology | 2006 | 247 |
| 8 | Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection | Gastroenterology | 2019 | 236 |
| 9 | Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy | Journal of Hepatology | 2020 | 219 |
| 10 | Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis | Gastroenterology | 2019 | 178 |
| 11 | Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus | Nature Communications | 2017 | 174 |
| 12 | Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals | American Journal of Physiology - Renal Physiology | 2019 | 162 |
| 13 | Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C | Hepatology | 2014 | 150 |
| 14 | Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites | Hepatology | 2016 | 146 |
| 15 | Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study | Hepatology | 2019 | 144 |
| 16 | The clinical course of cirrhosis: The importance of multistate models and competing risks analysis | Hepatology | 2015 | 136 |
| 17 | Branched-chain amino acids for people with hepatic encephalopathy | The Cochrane Library | 2017 | 136 |
| 18 | Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study | American Journal of Gastroenterology | 2018 | 134 |
| 19 | Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis | Scientific Reports | 2016 | 132 |
| 20 | Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease | Journal of Hepatology | 2019 | 128 |
| 21 | Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives | Movement Disorders | 2017 | 127 |
| 22 | Urea cycle dysregulation in non-alcoholic fatty liver disease | Journal of Hepatology | 2018 | 123 |
| 23 | Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study | PLoS ONE | 2016 | 123 |
| 24 | Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection | Clinical Infectious Diseases | 2017 | 122 |
| 25 | Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects | World Journal of Hepatology | 2019 | 122 |
| 26 | Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation | Mucosal Immunology | 2016 | 115 |
| 27 | Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS | Journal of Hepatology | 2020 | 112 |
| 28 | Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis | EClinicalMedicine | 2020 | 111 |
| 29 | The Liver–α-Cell Axis and Type 2 Diabetes | Endocrine Reviews | 2019 | 110 |
| 30 | Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease | Scandinavian Journal of Gastroenterology | 2016 | 109 |
| 31 | Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial | Lancet Oncology, The | 2017 | 108 |
| 32 | Normative Data for the Low Anterior Resection Syndrome Score (LARS Score) | Annals of Surgery | 2019 | 106 |
| 33 | Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study | Therapeutic Advances in Gastroenterology | 2016 | 105 |
| 34 | MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C | Nature Communications | 2016 | 104 |
| 35 | Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF) | Journal of Hepatology | 2016 | 104 |
| 36 | The Prevalence of Wilson’s Disease: An Update | Hepatology | 2020 | 103 |
| 37 | Development and Validation of a Comorbidity Scoring System for Patients With Cirrhosis | Gastroenterology | 2014 | 102 |
| 38 | Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement | Hepatology | 2021 | 102 |
| 39 | Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients | Hepatology | 2016 | 100 |
| 40 | Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms | Acta Oncológica | 2014 | 99 |
| 41 | The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease | Liver International | 2016 | 94 |
| 42 | Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson’s Disease: A Colon Transit and Volume Study | Journal of Parkinson's Disease | 2017 | 92 |
| 43 | IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis | Nature Genetics | 2017 | 86 |
| 44 | Cerebral effects of ammonia in liver disease: current hypotheses | Metabolic Brain Disease | 2014 | 84 |
| 45 | Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysis | Hepatology | 2016 | 84 |
| 46 | Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn′s Disease | Journal of Crohn's and Colitis | 2018 | 84 |
| 47 | Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study | American Journal of Gastroenterology | 2014 | 81 |
| 48 | Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial | Journal of Hepatology | 2022 | 79 |
| 49 | Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study | The Lancet Gastroenterology and Hepatology | 2020 | 76 |
| 50 | Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study | Annals of Surgical Oncology | 2016 | 73 |
